Blueprint Medicines Corp (NASDAQ:BPMC)

96.41
Delayed Data
As of May 14
 +3.71 / +4.00%
Today’s Change
60.82
Today|||52-Week Range
125.61
-14.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-52.8M-72.5M-148.1M-236.6M
 
 
 
 
 
Depreciation948.0K1.6M1.6M4.2M
 
 
 
 
 
Total Other Cash Flow5.7M6.5M12.2M26.1M
 
 
 
 
 
Funds From Operations-46.1M-64.4M-134.3M-206.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-14.4M-39.9M-14.4M-31.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-31.7M-24.5M-119.9M-175.0M
 
 
 
 
 
 
InvestingIncrease In Investments-1.2M-264.5M-364.3M-801.2M
 
 
 
 
 
Decrease In Investments0.0048.1M304.0M652.8M
 
 
 
 
Capital Expenditures-4.9M-2.4M-15.5M-12.7M
 
 
 
 
 
Net Cash Flow Investing-6.1M-218.7M-75.8M-161.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-1.8M-3.3M-2.6M-1.7M
 
 
 
 
 
Net Proceeds Stock Sale155.0M135.9M546.5M6.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing153.2M132.6M543.9M4.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash115.5M-110.6M348.2M-331.6M